Revisiting the Anti-Cancer Toxicity of Clinically Approved Platinating Derivatives

Cisplatin (CDDP), carboplatin (CP), and oxaliplatin (OXP) are three platinating agents clinically approved worldwide for use against a variety of cancers. They are canonically known as DNA damage inducers; however, that is only one of their mechanisms of cytotoxicity. CDDP mediates its effects throu...

Descripción completa

Detalles Bibliográficos
Autores principales: Forgie, Benjamin N., Prakash, Rewati, Telleria, Carlos M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793759/
https://www.ncbi.nlm.nih.gov/pubmed/36499737
http://dx.doi.org/10.3390/ijms232315410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793759/
https://www.ncbi.nlm.nih.gov/pubmed/36499737
http://dx.doi.org/10.3390/ijms232315410

Ejemplares similares